181 related articles for article (PubMed ID: 32119084)
21. Novel Approach for Obtaining Variable Domain of New Antigen Receptor with Different Physicochemical Properties from Japanese Topeshark (
Nakada-Masuta T; Takeda H; Uchida K
Mar Drugs; 2023 Oct; 21(11):. PubMed ID: 37999374
[TBL] [Abstract][Full Text] [Related]
22. IgNAR antibody: Structural features, diversity and applications.
Khalid Z; Chen Y; Yu D; Abbas M; Huan M; Naz Z; Mengist HM; Cao MJ; Jin T
Fish Shellfish Immunol; 2022 Feb; 121():467-477. PubMed ID: 35077867
[TBL] [Abstract][Full Text] [Related]
23. Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries.
Kolmar H; Grzeschik J; Könning D; Krah S; Zielonka S
Methods Mol Biol; 2023; 2702():227-243. PubMed ID: 37679622
[TBL] [Abstract][Full Text] [Related]
24. Transcriptomic analysis of immunoglobulin novel antigen receptor (IgNAR) heavy chain constant domains of brownbanded bamboo shark (Chiloscyllium punctatum).
De Silva DPN; Tan E; Mizuno N; Hosoya S; Reza MS; Watabe S; Kinoshita S; Asakawa S
Fish Shellfish Immunol; 2019 Jan; 84():370-376. PubMed ID: 30291985
[TBL] [Abstract][Full Text] [Related]
25. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of malaria PfHRP2 specific V
Leow CH; Fischer K; Leow CY; Braet K; Cheng Q; McCarthy J
Malar J; 2018 Oct; 17(1):383. PubMed ID: 30355309
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70.
Nuttall SD; Krishnan UV; Doughty L; Pearson K; Ryan MT; Hoogenraad NJ; Hattarki M; Carmichael JA; Irving RA; Hudson PJ
Eur J Biochem; 2003 Sep; 270(17):3543-54. PubMed ID: 12919318
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
[TBL] [Abstract][Full Text] [Related]
29. VNAR development through antigen immunization of Japanese topeshark (
Takeda H; Ozawa T; Zenke H; Ohnuki Y; Umeda Y; Zhou W; Tomoda H; Takechi A; Narita K; Shimizu T; Miyakawa T; Ito Y; Sawasaki T
Front Bioeng Biotechnol; 2023; 11():1265582. PubMed ID: 37771574
[TBL] [Abstract][Full Text] [Related]
30. Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.
Pandey SS; Kovaleva M; Barelle CJ; Ubah OC
Methods Mol Biol; 2022; 2446():19-33. PubMed ID: 35157267
[TBL] [Abstract][Full Text] [Related]
31. Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use.
Camacho-Villegas T; Mata-Gonzalez T; Paniagua-Solis J; Sanchez E; Licea A
MAbs; 2013; 5(1):80-5. PubMed ID: 23221782
[TBL] [Abstract][Full Text] [Related]
32. [Progress in shark single-domain antibody].
Liu X; Chen Q
Sheng Wu Gong Cheng Xue Bao; 2020 Jun; 36(6):1069-1082. PubMed ID: 32597058
[TBL] [Abstract][Full Text] [Related]
33. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing.
Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G
Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227
[TBL] [Abstract][Full Text] [Related]
34. Rapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic library.
Shao CY; Secombes CJ; Porter AJ
Mol Immunol; 2007 Jan; 44(4):656-65. PubMed ID: 16500706
[TBL] [Abstract][Full Text] [Related]
35. In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties.
Steven J; Ubah OC; Buschhaus M; Kovaleva M; Ferguson L; Porter AJ; Barelle CJ
Methods Mol Biol; 2020; 2070():115-142. PubMed ID: 31625093
[TBL] [Abstract][Full Text] [Related]
36. A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization.
Xi X; Xiao G; An G; Liu L; Liu X; Hao P; Wang JY; Song D; Yu W; Gu Y
Front Immunol; 2023; 14():1062656. PubMed ID: 36855630
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.
Kovaleva M; Johnson K; Steven J; Barelle CJ; Porter A
Front Immunol; 2017; 8():1121. PubMed ID: 28993766
[TBL] [Abstract][Full Text] [Related]
38. Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display.
Dooley H; Flajnik MF; Porter AJ
Mol Immunol; 2003 Sep; 40(1):25-33. PubMed ID: 12909128
[TBL] [Abstract][Full Text] [Related]
39. Generation and isolation of target-specific single-domain antibodies from shark immune repertoires.
Müller MR; O'Dwyer R; Kovaleva M; Rudkin F; Dooley H; Barelle CJ
Methods Mol Biol; 2012; 907():177-94. PubMed ID: 22907351
[TBL] [Abstract][Full Text] [Related]
40. Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications.
Juma SN; Gong X; Hu S; Lv Z; Shao J; Liu L; Chen G
Cells; 2021 May; 10(5):. PubMed ID: 34066890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
